Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis: a Pragmatic, Multi-center, Open-label Randomized Controlled Study

NCT07140211 is registered in ClinicalTrials.gov with Marc Blondon as lead sponsor.

NCT NCT07140211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07140211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis: a Pragmatic, Multi-center, Open-label Randomized Controlled Study
Lead sponsor
Marc Blondon
Phase
Phase 3
Overall status
Recruiting
Start date
October 15, 2025
Completion date
August 31, 2030
Enrollment
9,200 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum, venous thromboembolism (vte)